Targeted Therapy for Breast Cancer with Osteolytic Bone Damage

Grant

Date/time Interval

  • March 1, 2015 - February 29, 2020
  • Total Award Amount

  • 1656174.00
  • Direct Costs

  • 1136887.00
  • Sponsor Award Id

  • R01CA184770
  • Contributor

  • Gene Siegal M.D., Ph.D.   Investigator  
  • Selvarangan Ponnazhagan Ph.D.   Principal Investigator